← FDA Drug Approvals (Drugs@FDA)
BRIVARACETAM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2026-07-01
Drug application
- FDA Application #
ANDA219952- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BRIVARACETAM
- Generic name
- BRIVARACETAM
- Active ingredients
- BRIVARACETAM
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SCIEGEN PHARMS
- Manufacturer
- ScieGen Pharmaceuticals, Inc.
- First approval
- 2026-07-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown